Scholars Central

Conference abstract

EFFECTS OF BILIRUBIN ON METABOLIC SYNDROME IN TWO IN VITRO MODELS

Authors: Annalisa Bianco, Claudio Tiribelli, Cristina Bellarosa

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: Mildly elevated serum bilirubin in Gilbert Syndrome (GS) protects against diabetes, cardiovascular diseases (CVD) and metabolic syndrome (MetS). GS is a benign condition in which unconjugated hyperbilirubinemia occurs in the absence of structural liver disease and without hemolysis. It is caused by a genetic mutation that decreased the hepatic UGT1A1, the enzyme that mediates bilirubin glucuronidation. UGT1A1 variants in GS may confer a strong genetic advantage. Bilirubin, the final endogenous product of oxidative degradation of heme, plays a role in the cellular protection via scavenging peroxyl radicals and it prevents the oxidative modification of lipoproteins and lipids. Strategies to mimic GS may prove to be an attractive intervention in cardiovascular disease and metabolic syndrome. Aim: The aim is to study the protective role of mild hyperbilirubinemia on oxidative stress, inflammation and ER-stress in two in vitro models of MetS. Methods: Human kidney tubular epithelial HK-2 and murine heart endothelial H5V cell lines were treated respectively with Advanced Glycated End Products (AGE) and palmitic acid (PA). Cell viability, gene and protein expression, and intracellular ROS were evaluated. Results: PA treatments on H5V cells cause cell necrosis and mRNA induction of HO-1, IL-6, GRP78, CHOP, E-Selectin, V-CAM, ICAM and iNOS. UCB pre-treatment reverts cell necrosis, reduces CHOP, IL-6 and iNOS mRNA induction and increases HO-1 mRNA expression. CHOP protein induction by PA was also reduced. AGE treatment on HK-2 cells causes significative variation of IL-8, HIF1a, HO-1, GPX and Catalase mRNA expression and increases intracellular ROS. UCB pre-treatment increases the HO-1 and GPX mRNA, and reduces IL-8 and HIF1a mRNA induction and ROS intracellular levels. Conclusions: UCB plays a role in the modulation of cell viability, intracellular ROS production and mRNA gene expression in the in vitro models of diabetic nephropathy and atherosclerosis studied.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Diabetes Research and Endocrinology.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Diabetes Research and Endocrinology
  • SubjectDiabetes & Endocrinology
  • BylineArticles whose byline prints “Annalisa Bianco”
  • BylineArticles whose byline prints “Claudio Tiribelli”
  • BylineArticles whose byline prints “Cristina Bellarosa”